Detalhe da pesquisa
1.
Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire.
Ann Rheum Dis;
77(8): 1157-1164, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29695498
2.
Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Rheumatol Int;
38(4): 675-682, 2018 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29124398
3.
Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.
J Rheumatol;
46(10): 1415-1420, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30709951
4.
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.
J Rheumatol;
46(8): 928-934, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30824648
5.
Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.
Patient Relat Outcome Meas;
9: 17-34, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29379322
6.
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
J Rheumatol;
44(10): 1529-1535, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28864650
7.
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.
J Rheumatol;
42(11): 2204-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26329344
8.
Current status of outcome measure development in vasculitis.
J Rheumatol;
41(3): 593-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24429177